A detailed history of Jane Street Group, LLC transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 103,399 shares of MTNB stock, worth $73,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,399
Holding current value
$73,413
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.15 - $0.37 $15,509 - $38,257
103,399 New
103,399 $16,000
Q3 2023

Nov 14, 2023

BUY
$0.12 - $0.41 $4,140 - $14,146
34,503 New
34,503 $4,000
Q1 2023

May 15, 2023

SELL
$0.39 - $0.6 $57,377 - $88,273
-147,123 Reduced 71.74%
57,963 $27,000
Q4 2022

Feb 14, 2023

BUY
$0.46 - $42.69 $32,885 - $3.05 Million
71,490 Added 53.51%
205,086 $102,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $33.0 $18,354 - $961,422
-29,134 Reduced 17.9%
133,596 $85,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $33.0 $18,354 - $961,422
-29,134 Reduced 17.9%
133,596 $85,000
Q2 2022

Aug 16, 2022

BUY
$0.63 - $0.96 $92,747 - $141,330
147,219 Added 949.13%
162,730 $129,000
Q1 2022

May 17, 2022

BUY
$0.5 - $1.06 $7,755 - $16,441
15,511 New
15,511 $12,000
Q4 2021

Feb 15, 2022

SELL
$0.92 - $1.22 $149,169 - $197,812
-162,141 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$0.67 - $1.51 $92,357 - $208,148
137,847 Added 567.41%
162,141 $211,000
Q2 2021

Aug 16, 2021

BUY
$0.75 - $1.1 $524 - $768
699 Added 2.96%
24,294 $19,000
Q1 2021

May 18, 2021

SELL
$0.96 - $1.74 $1,716 - $3,111
-1,788 Reduced 7.04%
23,595 $25,000
Q4 2020

Feb 17, 2021

BUY
$0.76 - $1.47 $19,291 - $37,313
25,383 New
25,383 $35,000
Q3 2020

Nov 17, 2020

SELL
$0.67 - $0.96 $172,784 - $247,572
-257,888 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$0.52 - $0.92 $21,132 - $37,387
40,639 Added 18.71%
257,888 $199,000
Q1 2020

May 15, 2020

BUY
$0.6 - $2.31 $130,349 - $501,845
217,249 New
217,249 $130,000
Q3 2019

Nov 14, 2019

SELL
$0.59 - $0.9 $21,587 - $32,930
-36,589 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$0.79 - $1.11 $3,841 - $5,397
-4,863 Reduced 11.73%
36,589 $31,000
Q1 2019

May 16, 2019

BUY
$0.6 - $1.41 $16,299 - $38,302
27,165 Added 190.14%
41,452 $45,000
Q4 2018

Feb 15, 2019

BUY
$0.53 - $1.11 $7,572 - $15,858
14,287 New
14,287 $9,000
Q3 2018

Nov 14, 2018

SELL
$0.35 - $0.92 $9,657 - $25,385
-27,593 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$0.42 - $0.74 $11,589 - $20,418
27,593 New
27,593 $12,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $154M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.